[go: up one dir, main page]

AR019023A1 - Uso de 1'-[4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil]3-spiro[isobenzofuran-1(3h), 4'-piperidina] en el tratamiento de los ataques de panico. - Google Patents

Uso de 1'-[4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil]3-spiro[isobenzofuran-1(3h), 4'-piperidina] en el tratamiento de los ataques de panico.

Info

Publication number
AR019023A1
AR019023A1 ARP990101556A ARP990101556A AR019023A1 AR 019023 A1 AR019023 A1 AR 019023A1 AR P990101556 A ARP990101556 A AR P990101556A AR P990101556 A ARP990101556 A AR P990101556A AR 019023 A1 AR019023 A1 AR 019023A1
Authority
AR
Argentina
Prior art keywords
isobenzofuran
spiro
piperidine
treatment
attacks
Prior art date
Application number
ARP990101556A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR019023A1 publication Critical patent/AR019023A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de 1-[4-[1-(4-fluorofenil)-1H-indol-3-il]-1-butil]-spiro [isobenzofuran-1(3H), 4-piperidina] o una sal farmacéuticamente aceptable de la misma, parala preparacion de un medicamento para el tratamiento de los ataques de pánico.
ARP990101556A 1998-04-07 1999-04-06 Uso de 1'-[4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil]3-spiro[isobenzofuran-1(3h), 4'-piperidina] en el tratamiento de los ataques de panico. AR019023A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK50198 1998-04-07

Publications (1)

Publication Number Publication Date
AR019023A1 true AR019023A1 (es) 2001-12-26

Family

ID=8094284

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101556A AR019023A1 (es) 1998-04-07 1999-04-06 Uso de 1'-[4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil]3-spiro[isobenzofuran-1(3h), 4'-piperidina] en el tratamiento de los ataques de panico.

Country Status (23)

Country Link
US (1) US6262061B1 (es)
EP (1) EP1069899A1 (es)
JP (1) JP2002510626A (es)
KR (1) KR20010042502A (es)
CN (1) CN1296409A (es)
AR (1) AR019023A1 (es)
AU (1) AU3025899A (es)
BG (1) BG104814A (es)
BR (1) BR9909598A (es)
CA (1) CA2325948A1 (es)
EA (1) EA200001032A1 (es)
HR (1) HRP20000659A2 (es)
HU (1) HUP0101706A3 (es)
ID (1) ID28335A (es)
IL (1) IL138484A0 (es)
IS (1) IS5636A (es)
NO (1) NO20005062L (es)
PL (1) PL342989A1 (es)
SK (1) SK14842000A3 (es)
TR (1) TR200002891T2 (es)
WO (1) WO1999051229A1 (es)
YU (1) YU58900A (es)
ZA (1) ZA200004856B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141880A0 (en) * 1998-09-15 2002-03-10 Lundbeck & Co As H Treatment of depression
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
WO2004110388A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
NO20005062L (no) 2000-11-30
HUP0101706A2 (hu) 2001-11-28
HUP0101706A3 (en) 2003-03-28
BR9909598A (pt) 2000-11-21
AU3025899A (en) 1999-10-25
HRP20000659A2 (en) 2001-04-30
NO20005062D0 (no) 2000-10-06
KR20010042502A (ko) 2001-05-25
ZA200004856B (en) 2001-08-29
IS5636A (is) 2000-09-22
IL138484A0 (en) 2001-10-31
YU58900A (sh) 2002-11-15
PL342989A1 (en) 2001-07-16
BG104814A (en) 2001-04-30
WO1999051229A1 (en) 1999-10-14
TR200002891T2 (tr) 2001-02-21
EP1069899A1 (en) 2001-01-24
CN1296409A (zh) 2001-05-23
CA2325948A1 (en) 1999-10-14
US6262061B1 (en) 2001-07-17
ID28335A (id) 2001-05-10
SK14842000A3 (sk) 2001-06-11
JP2002510626A (ja) 2002-04-09
EA200001032A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
FI934220L (fi) Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
FI955091A7 (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät al koholia ja hydrofobista lääkettä
TR200402579T4 (tr) Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
EA199800971A1 (ru) Способ лечения новообразований, вкючающий применение ингибиторов протеиназы с
FI921459A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
AR002157A1 (es) Uso de una dosis inmunizante eficaz de esporozoitos o merozoitos de eimeria vivos, o una mezcla de los mismos
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
IS5460A (is) 1´-[4-[1-(4-flúorófenýl)-1H-indól-3-ýl]-1-bútýl]-spíró [ísóbensófúran-1 (3H), 4´-píperídín]hýdrohalógeníð
AR019023A1 (es) Uso de 1'-[4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil]3-spiro[isobenzofuran-1(3h), 4'-piperidina] en el tratamiento de los ataques de panico.
EP1186318A3 (en) Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist
AU3476397A (en) Therapeutic treatment for cardiovascular diseases
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
SE9302218D0 (sv) New use
ES2122953T3 (es) Uso de inhibidores de pck para la fabricacion de un medicamento para el tratamiento de disfunciones sexuales.
EP0940142A3 (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU2001279607A1 (en) Pharmaceutical composition containing 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl) -1-butyl)-spiro(isobenzofuran-1(3h),4'-piperidine)
NO921723D0 (no) Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
EP0940143A3 (en) Use of PKC-inhibitors for the manufacture of a medicament for the treatment of asthma
CA2242406A1 (en) Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
DK0946580T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK444389A (da) Makrocycliske forbindelser, fremgangsmaade til deres fremstilling samt deres anvendelse som mikrobicider
DK444489A (da) Makrocycliske forbindelser, fremgangsmaade til deres fremstilling samt deres anvendelse som mikrobicider